Cargando…

Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study

BACKGROUND: New research criteria for the diagnosis of Alzheimer’s disease (AD) have recently been developed to enable an early diagnosis of AD pathophysiology by relying on emerging biomarkers. To enable efficient allocation of health care resources, evidence is needed to support decision makers on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handels, Ron LH, Aalten, Pauline, Wolfs, Claire AG, OldeRikkert, Marcel, Scheltens, Philip, Visser, Pieter Jelle, Joore, Manuela A, Severens, Johan L, Verhey, Frans RJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460756/ https://www.ncbi.nlm.nih.gov/pubmed/22883691 http://dx.doi.org/10.1186/1471-2377-12-72

Ejemplares similares

Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes
por: Handels, Ron L H, et al.
Publicado: (2014)

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
por: Vos, Stephanie J. B., et al.
Publicado: (2014)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial
por: Linden, Iris, et al.
Publicado: (2021)

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

Cost-Effectiveness of One Year Dementia Follow-Up Care by Memory Clinics or General Practitioners: Economic Evaluation of a Randomised Controlled Trial
por: Meeuwsen, Els, et al.
Publicado: (2013)

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports
por: Slats, Diane, et al.
Publicado: (2010)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results
por: Aalten, Pauline, et al.
Publicado: (2014)

Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia
por: Banning, Leonie C. P., et al.
Publicado: (2019)

A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands
por: Liao, Weiqi, et al.
Publicado: (2016)

The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence: The PromoCon study (Promoting Continence)
por: Albers-Heitner, Pytha, et al.
Publicado: (2008)

The feasibility and validity of a preference-weighted composite endpoint to establish value in geriatric care
por: Hofman, Cynthia, et al.
Publicado: (2014)

Cognitive and functional progression of dementia in two longitudinal studies
por: Wang, Yuwei, et al.
Publicado: (2019)

Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease
por: König, Alexandra, et al.
Publicado: (2015)

Pre-trained MRI-based Alzheimer's disease classification models to classify memory clinic patients
por: de Vos, Frank, et al.
Publicado: (2020)

The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
por: König, Alexandra, et al.
Publicado: (2015)

Memory enhancing drugs and Alzheimer’s Disease: Enhancing the self or preventing the loss of it?
por: Dekkers, Wim, et al.
Publicado: (2007)

A new combined strategy to implement a community occupational therapy intervention: designing a cluster randomized controlled trial
por: Döpp, Carola ME, et al.
Publicado: (2011)

Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial
por: Willems, Daniëlle CM, et al.
Publicado: (2007)

Can novel therapeutics halt the amyloid cascade?
por: Prins, Niels D, et al.
Publicado: (2010)

Economic evaluation of implementation strategies in health care
por: Hoomans, Ties, et al.
Publicado: (2014)

Screen or not to screen for peripheral arterial disease: guidance from a decision model
por: Vaidya, Anil, et al.
Publicado: (2014)

Imaging Markers of Post-Stroke Depression and Apathy: a Systematic Review and Meta-Analysis
por: Douven, Elles, et al.
Publicado: (2017)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

Development of memory clinics in the Netherlands over the last 20 years
por: Gruters, Angélique A.A., et al.
Publicado: (2019)

Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
por: Zwan, Marissa D., et al.
Publicado: (2017)

A validation study of the ICECAP-O in informal carers of people with dementia from eight European Countries
por: Perry-Duxbury, Meg, et al.
Publicado: (2019)

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan
por: Mandrik, Olena, et al.
Publicado: (2015)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
por: Vromen, Eleonora M., et al.
Publicado: (2022)

Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline
por: Janssen, Niels, et al.
Publicado: (2022)

Health-related quality of life after fast-track treatment results from a randomized controlled clinical equivalence trial
por: van Mastrigt, Ghislaine A. P. G., et al.
Publicado: (2010)

Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a mapping study
por: Rombach, Ines, et al.
Publicado: (2020)

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
por: Vermunt, Lisa, et al.
Publicado: (2019)

REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE
por: Mandrik, Olena, et al.
Publicado: (2015)

Health economic modeling for Alzheimer's disease: Expert perspectives
por: Landeiro, Filipa, et al.
Publicado: (2022)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
por: Konijnenberg, Elles, et al.
Publicado: (2020)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
por: Tijms, Betty Marije, et al.
Publicado: (2021)

Imaging markers associated with the development of post-stroke depression and apathy: Results of the Cognition and Affect after Stroke – a Prospective Evaluation of Risks study
por: Douven, Elles, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3det63itg81bfa1hdjmre9be6r